title: Infliximab therapy for inflammatory discitis in ankylosing spondylitis.
authors.affiliation: Colchester Hospital University NHS Foundation Trust, Colchester, UK.
authors.forename: Nilay
authors.initials: N
authors.lastname: Joshi
authors.forename: Amit
authors.initials: A
authors.lastname: Nautiyal
authors.forename: Tom
authors.initials: T
authors.lastname: Walton
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D001706:Biopsy; D002637:Chest Pain / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D015299:Discitis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D011859:Radiography; D020127:Recovery of Function / Q000187:drug effects; D012074:Remission Induction / Q000379:methods; D012720:Severity of Illness Index; D013167:Spondylitis, Ankylosing / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D013904:Thoracic Vertebrae / Q000000981:diagnostic imaging / Q000503:physiopathology; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab